Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 14;80(20):1850-5.
doi: 10.1212/WNL.0b013e318292a31d. Epub 2013 Apr 17.

Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD

Affiliations

Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD

Clare Loane et al. Neurology. .

Abstract

Objective: The underlying pathophysiology of tremor in Parkinson disease (PD) is unclear; however, it is known that tremor does not appear to be as responsive to dopaminergic medication as bradykinesia or rigidity. It is suggested that serotonergic dysfunction could have a role in tremor development.

Methods: Using (11)C-DASB PET, a marker of serotonin transporter binding, and clinical observations, we have investigated function of serotonergic terminals in 12 patients with tremor-predominant and 12 with akinetic-rigid PD. Findings were compared with those of 12 healthy controls.

Results: Reductions of (11)C-DASB in caudate, putamen, and raphe nuclei significantly correlated with tremor severity on posture and action, but not with resting tremor. The tremor-predominant group also showed reductions of (11)C-DASB in other regions involved in motor circuitry, including the thalamus and Brodmann areas 4 and 10.

Conclusions: Our findings support a role for serotonergic dysfunction in motor circuitries in the generation of postural tremor in PD.

PubMed Disclaimer

Figures

Figure 1
Figure 1. 11C-DASB binding in normal controls and patients with tremor-predominant PD and akinetic-rigid PD and correlation of 11C-DASB binding and action-postural tremor in the tremor-predominant PD group
11C-DASB BPND values of 12 healthy controls, 12 patients with bradykinetic PD, and 12 patients with tremor-predominant PD in (A) caudate, (B) putamen, and (C) raphe nuclei. Significant correlations between increased AP tremor scores and reduced 11C-DASB BPND values in (D) caudate (r = −0.80, p < 0.001), (E) putamen (r = −0.74, p < 0.005), and (F) raphe nuclei (r = −0.78, p < 0.005) in 12 patients with tremor-predominant PD. *p < 0.005. AP = action-postural; BPND = nondisplaceable binding potential; 11C-DASB = 11C-labeled 3-amino-4-[2-[(di(methyl)amino)methyl]phenyl]sulfanylbenzonitrile; PD = Parkinson disease.
Figure 2
Figure 2. Motor circuitries in the human brain
(A) Diagrammatic representation of the major motor circuitries in the human brain. The regions and interregional circuitry identified in this study to be associated with action-postural tremor in PD are highlighted in red. Summed 11C-DASB PET images in transverse, sagittal, and coronal planes showing regions of 5-HT loss within the motor pathway: (B) rostral raphe nuclei; (C) caudate, putamen, and thalamus; (D) Brodmann area 10; and (E) Brodmann area 4, the primary motor area (PMA). Color bar reflects z scores (BPND range: 0–12). BPND = nondisplaceable binding potential; 11C-DASB = 11C-labeled 3-amino-4-[2-[(di(methyl)amino)methyl]phenyl]sulfanylbenzonitrile;5-HT = serotonin; PD = Parkinson disease.

References

    1. Rajput A. Clinical features of tremor in extrapyramidal syndromes. In: Findley LJ, Koller WC, editors. Handbook of Tremor Disorders. New York: Marcel Dekker; 1995:275–291
    1. Kish SJ, Tong J, Hornykiewicz O, et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008;131;120–131 - PubMed
    1. Politis M, Wu K, Loane C, et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol Dis 2010;40:216–221 - PubMed
    1. Politis M, Loane C, Wu K, Brooks DJ, Piccini P. Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiol Dis 2010;43:609–615 - PubMed
    1. Politis M, Wu K, Loane C, et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010;75:1920–1927 - PubMed

Publication types

MeSH terms

Substances